be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Final Report - analytica closes with record-breaking visitor attendance
The 26th analytica m...
MINICUBE PCR A NEW TOOL FOR GENETIC RESEARCH
The importance of research in our genes cannot ...
Bioeconomy drives Lodzkie. Americans are looking up to us
Close to a thousand participants, ...
Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidate
Pharnext Announces Positive Topline Results from Pivotal Phase 3 Trial of PXT3003 for Treatment of Charcot-Marie-Tooth Type 1A Disease

Tag filter

poland

pharma

europe

bosnia

Most popular

searches

All articles

Filters:

Show search box

2013-02-22

Mabion targets Bosnia

Mabion targets Bosnia

Mabion SA submitted in Bosnia full set of R&D and legal documents in order to register clinical trials of MabionCD20 medicine, which is used in therapy of blood cancers and rheumatoid arthritis (RA). The application was delivered to 6 bioethical commissions in Bosnia and in the Council of Registratio... Read more

Tags poland , pharma , europe , bosnia